This website uses cookies

The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.

Profil

Vandermeers Fabian

See author's contact details
Main Referenced Co-authors
Willems, Luc  (14)
Burny, Arsène  (7)
Kettmann, Richard  (6)
Florins, Arnaud-Francois  (5)
Gillet, Nicolas  (5)
Main Referenced Keywords
Animals (4); BLV (3); Humans (3); Sheep (3); valproate (3);
Main Referenced Disciplines
Oncology (10)
Biochemistry, biophysics & molecular biology (4)
Veterinary medicine & animal health (4)
Immunology & infectious disease (1)
Animal production & animal husbandry (1)

Publications (total 18)

The most downloaded
608 downloads
Florins, A.-F., Gillet, N., Asquith, B., Boxus, M., Burteaux, C., Twizere, J.-C., Urbain, P., Vandermeers, F., Debacq, C., Sanchez-alcaraz, M. T., Schwartz-Cornil, I., Kerkhofs, P., Jean, G., Thewis, A., Hay, J., Mortreux, F., Wattel, E., Reichert, M., Burny, A., ... Willems, L. (2007). Cell dynamics and immune response to BLV infection: a unifying model. Frontiers in Bioscience-Landmark, 12, 1520-1531. doi:10.2741/2165 https://hdl.handle.net/2268/20537

The most cited

367 citations (OpenAlex)

Gillet, N., Florins, A.-F., Boxus, M., Burteau, C., Nigro, A., Vandermeers, F., Balon, H., Bouzar, A., Defoiche, J., Burny, A., Reichert, M., Kettmann, R., & Willems, L. (2007). Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology, 4 (1), 18. doi:10.1186/1742-4690-4-18 https://hdl.handle.net/2268/10555

Articles accepted in reviewed journal

Hubaux, R., Vandermeers, F., Cosse, J.-P., Crisanti, C., Kapoor, V., Albelda, S. M., Mascaux, C., Delvenne, P., Hubert, P., & Willems, L. (19 October 2015). Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models. ERJ Open Research, 1 (2), 00028. doi:10.1183/23120541.00028-2015
Peer Reviewed verified by ORBi

Gillet, N., Vandermeers, F., De Brogniez, A., Florins, A., Nigro, A., François, C., Bouzar, A.-B., Verlaeten, O., Stern, E., Lambert, D., Wouters, J., & Willems, L. (2012). Chemoresistance to Valproate Treatment of Bovine Leukemia Virus-Infected Sheep; Identification of Improved HDAC Inhibitors. Pathogens, (2012-1), 65-82. doi:10.3390/pathogens1020065
Peer Reviewed verified by ORBi

Hubaux, R., Vandermeers, F., Crisanti, C., Kapoor, V., Burny, A., Mascaux, C., Albelda, S. M., & Willems, L. (09 June 2010). Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy. European Journal of Cancer, 46, 1724-1734. doi:10.1016/j.ejca.2010.03.021
Peer Reviewed verified by ORBi

Crisanti, C., Wallace, A., Kapoor, V., Vandermeers, F., Dowling, M., Pereira, L., Coleman, K., Campling, B., Fridlender, Z., Kao, G., & Albelda, S. (August 2009). The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer. Molecular Cancer Therapeutics, 8 (8), 2221-2231. doi:10.1158/1535-7163.MCT-09-0138
Peer Reviewed verified by ORBi

Vandermeers, F., Hubert, P., Delvenne, P., Mascaux, C., Grigoriu, B., Burny, A., Scherpereel, A., & Willems, L. (2009). Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Clinical Cancer Research, 15 (8), 2818-28. doi:10.1158/1078-0432.CCR-08-1579
Peer Reviewed verified by ORBi

Vandermeers, F., Kettmann, R., & Willems, L. (2008). Implication des modifications épigénétiques dans les cancers : développement de nouvelles approches thérapeutiques. Biotechnologie, Agronomie, Société et Environnement, 12 (2).
Peer Reviewed verified by ORBi

Florins, A.-F., Boxus, M., Vandermeers, F., Verlaeten, O., Bouzar, A., Defoiche, J., Hubaux, R., Burny, A., Kettmann, R., & Willems, L. (2008). Emphasis on cell turnover in two hosts infected by bovine leukemia virus: a rationale for host susceptibility to disease. Veterinary Immunology and Immunopathology, 125 (1-2), 1-7. doi:10.1016/j.vetimm.2008.04.007
Peer Reviewed verified by ORBi

Gillet, N., Florins, A.-F., Boxus, M., Burteau, C., Nigro, A., Vandermeers, F., Balon, H., Bouzar, A., Defoiche, J., Burny, A., Reichert, M., Kettmann, R., & Willems, L. (2007). Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology, 4 (1), 18. doi:10.1186/1742-4690-4-18
Peer Reviewed verified by ORBi

Florins, A.-F., Gillet, N., Asquith, B., Boxus, M., Burteaux, C., Twizere, J.-C., Urbain, P., Vandermeers, F., Debacq, C., Sanchez-alcaraz, M. T., Schwartz-Cornil, I., Kerkhofs, P., Jean, G., Thewis, A., Hay, J., Mortreux, F., Wattel, E., Reichert, M., Burny, A., ... Willems, L. (2007). Cell dynamics and immune response to BLV infection: a unifying model. Frontiers in Bioscience-Landmark, 12, 1520-1531. doi:10.2741/2165
Peer Reviewed verified by ORBi

Florins, A.-F., Gillet, N., Boxus, M., Verlaeten, O., Nigro, A., Vandermeers, F., Burteau, C., Balon, H., Bouzar, A., Defoiche, J., Burny, A., Kettmann, R., & Willems, L. (2007). Dynamique cellulaire de la pathogenèse induite par le virus de la leucémie bovine. Virologie. doi:10.1684/vir.2007.0134
Peer reviewed

Achachi, A.* , Florins, A.-F.* , Gillet, N.* , Debacq, C., Urbain, P., Foutsop, G. M., Vandermeers, F., Jasik, A., Reichert, M., Kerkhofs, P., Lagneaux, L., Burny, A., Kettmann, R., & Willems, L. (2005). Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proceedings of the National Academy of Sciences of the United States of America, 102 (29), 10309-14. doi:10.1073/pnas.0504248102
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Contact ORBi